Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Specification of Sprouty2 functions in osteogenesis in in vivo context

B. Vesela, E. Svandova, M. Hovorakova, R. Peterkova, A. Kratochvilova, M. Pasovska, A. Ramesova, H. Lesot, E. Matalova,

. 2019 ; 15 (4) : 111-119. [pub] 20190904

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc20022965

Sprouty proteins are modulators of the MAPK/ERK pathway. Amongst these, Sprouty2 (SPRY2) has been investigated as a possible factor that takes part in the initial phases of osteogenesis. However, the in vivo context has not yet been investigated and the underlying mechanisms taking place in vitro remain unknown. Therefore, in this study, the impact of Spry2 deficiency was examined in the developing tibias of Spry2 deficient (-/-) mouse. The investigation was performed when the osteogenic zone became clearly visible and when all three basic bone cells types were present. The main markers of osteoblasts, osteocytes and osteoclasts were evaluated by immunohistochemistry and RT-PCR. RT-PCR showed that the expression of Sost was 3.5 times higher in Spry2-/- than in the wild-type bone, which pointed to a still unknown mechanism of action of SPRY2 on the differentiation of osteocytes. The up-regulation of Sost was independent of Hif-1α expression and could not be related to its positive regulator, Runx2, since none of these factors showed an increased expression in the bone of Spry2-/- mice. Regarding the RANK/RANKL/OPG pathway, the Spry2-/- showed an increased expression of Rank, but no significant change in the expression of Rankl and Opg. Thanks to these results, the impact of Spry2 deletion is shown for the first time in the developing bone as a complex organ including, particularly, an effect on osteoblasts (Runx2) and osteocytes (Sost). This might explain the previously reported decrease in bone formation in postnatal Spry2-/- mice.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20022965
003      
CZ-PrNML
005      
20230510130052.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1080/15476278.2019.1656995 $2 doi
035    __
$a (PubMed)31480885
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vesela, Barbora $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences , Brno , Czech Republic.
245    10
$a Specification of Sprouty2 functions in osteogenesis in in vivo context / $c B. Vesela, E. Svandova, M. Hovorakova, R. Peterkova, A. Kratochvilova, M. Pasovska, A. Ramesova, H. Lesot, E. Matalova,
520    9_
$a Sprouty proteins are modulators of the MAPK/ERK pathway. Amongst these, Sprouty2 (SPRY2) has been investigated as a possible factor that takes part in the initial phases of osteogenesis. However, the in vivo context has not yet been investigated and the underlying mechanisms taking place in vitro remain unknown. Therefore, in this study, the impact of Spry2 deficiency was examined in the developing tibias of Spry2 deficient (-/-) mouse. The investigation was performed when the osteogenic zone became clearly visible and when all three basic bone cells types were present. The main markers of osteoblasts, osteocytes and osteoclasts were evaluated by immunohistochemistry and RT-PCR. RT-PCR showed that the expression of Sost was 3.5 times higher in Spry2-/- than in the wild-type bone, which pointed to a still unknown mechanism of action of SPRY2 on the differentiation of osteocytes. The up-regulation of Sost was independent of Hif-1α expression and could not be related to its positive regulator, Runx2, since none of these factors showed an increased expression in the bone of Spry2-/- mice. Regarding the RANK/RANKL/OPG pathway, the Spry2-/- showed an increased expression of Rank, but no significant change in the expression of Rankl and Opg. Thanks to these results, the impact of Spry2 deletion is shown for the first time in the developing bone as a complex organ including, particularly, an effect on osteoblasts (Runx2) and osteocytes (Sost). This might explain the previously reported decrease in bone formation in postnatal Spry2-/- mice.
650    _2
$a zvířata $7 D000818
650    _2
$a vývoj kostí $7 D001846
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a proliferace buněk $7 D049109
650    _2
$a cytoplazma $x metabolismus $7 D003593
650    12
$a vývojová regulace genové exprese $7 D018507
650    _2
$a faktor 1 indukovatelný hypoxií - podjednotka alfa $x metabolismus $7 D051795
650    _2
$a membránové proteiny $x genetika $x fyziologie $7 D008565
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední ICR $7 D008813
650    _2
$a myši knockoutované $7 D018345
650    _2
$a osteoblasty $x cytologie $x metabolismus $7 D010006
650    _2
$a osteoklasty $x cytologie $x metabolismus $7 D010010
650    _2
$a osteocyty $x cytologie $x metabolismus $7 D010011
650    12
$a osteogeneze $7 D010012
650    _2
$a osteoprotegerin $x metabolismus $7 D053244
650    _2
$a protein-serin-threoninkinasy $x genetika $x fyziologie $7 D017346
650    _2
$a ligand RANK $x metabolismus $7 D053245
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Svandova, Eva $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences , Brno , Czech Republic.
700    1_
$a Hovorakova, Maria $u Department of Developmental Biology, Institute of Experimental Medicine, Czech Academy of Sciences , Prague , Czech Republic.
700    1_
$a Peterkova, Renata $u Department of Histology and Embryology, Third Faculty of Medicine, Charles University , Prague , Czech Republic.
700    1_
$a Kratochvílová, Adéla $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences , Brno , Czech Republic. $7 xx0301396
700    1_
$a Pasovska, Martina $u Department of Developmental Biology, Institute of Experimental Medicine, Czech Academy of Sciences , Prague , Czech Republic. Department of Anthropology and Human Genetics, Faculty of Science, Charles University , Prague , Czech Republic.
700    1_
$a Ramesova, Alice $u Department of Physiology, University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic.
700    1_
$a Lesot, Herve $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences , Brno , Czech Republic.
700    1_
$a Matalova, Eva $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences , Brno , Czech Republic. Department of Physiology, University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic.
773    0_
$w MED00186379 $t Organogenesis $x 1555-8592 $g Roč. 15, č. 4 (2019), s. 111-119
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31480885 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20230510130047 $b ABA008
999    __
$a ok $b bmc $g 1595284 $s 1113641
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 15 $c 4 $d 111-119 $e 20190904 $i 1555-8592 $m Organogenesis $n Organogenesis $x MED00186379
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Archiving options